William L Baker

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 35

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Systematic Review

Cardiovascular Events

Top Venues

Pharmacotherapy

Progress in transplantation (Aliso Viejo, Calif.)

Hypertension (Dallas, Tex. : 1979)

Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors

This page only lists publications with an associated author ORCID identifier.

Publications

C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernández, William L Baker, Paul P Dobesh, Heleen van Haalen, Kirsty M Rhodes, Craig I Coleman
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy (2024)
C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernández, William L Baker, Paul P Dobesh, Heleen van Haalen, Kirsty M Rhodes, Craig I Coleman
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy 44 (5) (2024)
C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernández, William L Baker, Paul P Dobesh, Heleen van Haalen, Kirsty M Rhodes, Craig I Coleman
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy 44 (5) (2024)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy 43 (2) (2023)
William L Baker
Comment on "Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy". Pharmacotherapy 43 (4) (2023)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing Policy Change on Induction Immunosuppression Practice Patterns and Outcomes in Adult Heart Transplant Recipients. Pharmacotherapy (2023)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy 43 (2) (2023)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy 43 (2) (2023)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy 43 (2) (2023)
William L Baker
Comment on "Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy". Pharmacotherapy 43 (4) (2023)
Douglas L Jennings, William L Baker
Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy (2023)
William L Baker
Comment on "Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy". Pharmacotherapy 43 (4) (2023)
William L Baker
Comment on "Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy". Pharmacotherapy 43 (4) (2023)
William L Baker, Cynthia A Jackevicius
Exploring the frontier of cardiovascular pharmacotherapy. Pharmacotherapy 41 (12) (2022)
William L Baker, Timothy E Moore, Eric Baron, Douglas L Jennings, Abhishek Jaiswal
Development and Validation of a Model to Predict Malignancy Within the First Year After Adult Heart Transplantation. Progress in transplantation (Aliso Viejo, Calif.) (2022)
Abhishek Jaiswal, David A Baran, Supanee Sinphurmsukskul, William L Baker
Cardiac donors with renal impairment: Usage and outcomes after heart transplant. Clinical transplantation 36 (9) (2022)
William L Baker, Timothy E Moore, Eric Baron, Douglas L Jennings, Abhishek Jaiswal
Development and Validation of a Model to Predict Malignancy Within the First Year After Adult Heart Transplantation. Progress in transplantation (Aliso Viejo, Calif.) 33 (1) (2022)
William L Baker, Timothy E Moore, Eric Baron, Douglas L Jennings, Abhishek Jaiswal
Development and Validation of a Model to Predict Malignancy Within the First Year After Adult Heart Transplantation. Progress in transplantation (Aliso Viejo, Calif.) 33 (1) (2022)
William L Baker, Timothy E Moore, Eric Baron, Douglas L Jennings, Abhishek Jaiswal
Development and Validation of a Model to Predict Malignancy Within the First Year After Adult Heart Transplantation. Progress in transplantation (Aliso Viejo, Calif.) 33 (1) (2022)
Leo F Buckley, William L Baker, Benjamin W Van Tassell, Jordana B Cohen, Omar S Alkhezi, Adam P Bress, Dave L Dixon
Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events. Hypertension (Dallas, Tex. : 1979) (2022)
William L Baker, Timothy E Moore, Eric Baron, Douglas L Jennings, Abhishek Jaiswal
Development and Validation of a Model to Predict Malignancy Within the First Year After Adult Heart Transplantation. Progress in transplantation (Aliso Viejo, Calif.) 33 (1) (2022)
Azita H Talasaz, Ai-Chen Jane Ho, Fawzia Bhatty, Rachel A Koenig, Dave L Dixon, William L Baker, Benjamin W Van Tassell
Meta-analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD. Pharmacotherapy (2021)
Craig I Coleman, Akshay A Kharat, Brahim Bookhart, William L Baker
Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease. Current medical research and opinion (2021)
William L Baker, Sobieraj D M, Robert J DiDomenico
Influence of digoxin on mortality in patients with atrial fibrillation: Overview of systematic reviews. Pharmacotherapy 41 (4) (2021)
Dave L Dixon, William L Baker, Leo F Buckley, Teresa M Salgado, Benjamin W Van Tassell, Barry L Carter
Effect of a Physician/Pharmacist Collaborative Care Model on Time in Target Range for Systolic Blood Pressure: Post Hoc Analysis of the CAPTION Trial. Hypertension (Dallas, Tex. : 1979) 78 (4) (2021)
Douglas L Jennings, Naga Vaishnavi Gadela, Abhishek Jaiswal, Amanda Touch, William L Baker
Pre-transplant amiodarone use does not affect long-term heart transplant survival. Pharmacotherapy (2021)
Benjamin Miao, Adrian V Hernandez, Yuani M Roman, Mark J Alberts, Craig I Coleman, William L Baker
Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation. Clinical cardiology 43 (5) (2020)
Kathleen K Adams, William L Baker, Sobieraj D M
Myth Busters: Dietary Supplements and COVID-19. The Annals of pharmacotherapy 54 (8) (2020)
Cassandra Doyno, Diana M Sobieraj, William L Baker
Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. Clinical toxicology (Philadelphia, Pa.) 59 (1) (2020)
Diana M Sobieraj, Brandon K Martinez, Benjamin Miao, Mark X Cicero, Richard A Kamin, Adrian V Hernandez, Craig I Coleman, William L Baker
Comparative Effectiveness of Analgesics to Reduce Acute Pain in the Prehospital Setting. Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 24 (2) (2019)
Brandon K Martinez, William L Baker, Nitesh A Sood, Thomas J Bunz, Anna-Katharina Meinecke, Daniel Eriksson, Craig I Coleman
Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation. Pharmacotherapy 39 (2) (2019)
Diana M Sobieraj, Brandon K Martinez, Adrian V Hernandez, Craig I Coleman, Joseph S Ross, Karina M Berg, David C Steffens, William L Baker
Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults. Journal of the American Geriatrics Society 67 (8) (2019)
William L Baker, Samantha Steiger, Spencer Martin, Nirav Patel, Joseph Radojevic, Konstadina Darsaklis, Lynn O'Bara, Heather Kutzler, James Dougherty, Andrew Feingold, Jonathan Hammond, Daniel Fusco, Jason A Gluck
Association Between Time-in-Therapeutic Tacrolimus Range and Early Rejection After Heart Transplant. Pharmacotherapy 39 (5) (2019)
Stephanie E Trexler, Elaine Nguyen, Samantha M Gromek, Marcy J Balunas, William L Baker
Electrocardiographic effects of hawthorn (Crataegus oxyacantha) in healthy volunteers: A randomized controlled trial. Phytotherapy research : PTR 32 (8) (2018)
Brandon K Martinez, Brenda Yik, Raymond Tran, Sabrina Ilham, Craig I Coleman, Douglas L Jennings, William L Baker
Meta-Analysis of Time in Therapeutic Range in Continuous-Flow Left Ventricular Assist Device Patients Receiving Warfarin. Artificial organs 42 (7) (2018)